Leerink Partners analyst Richard Newitter maintained a Buy rating on Align Tech (NASDAQ:ALGN) on Wednesday, setting a price target of $770, which is approximately 10.66% above the present share price of $695.8.
Newitter expects Align Tech to post earnings per share (EPS) of $2.53 for the third quarter of 2021.
The current consensus among 8 TipRanks analysts is for a Strong Buy rating of shares in Align Tech, with an average price target of $753.86.
The analysts price targets range from a high of $790 to a low of $700.
In its latest earnings report, released on 06/30/2021, the company reported a quarterly revenue of $1.01 billion and a net profit of $268.9 million. The company's market cap is $55.06 billion.
According to TipRanks.com, Leerink Partners analyst Richard Newitter is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 24.2% and a 66.93% success rate.
Founded in 1997, Align Technology , Inc. is a global medical devices company based in California. It manufactures 3D digital scanners and clear aligners used in orthodontics. The company operates through the Clear Aligner, and Scanner and Services segments.